Save time and get answers to complex questions with AI chat
Prolia and osteonecrosis?Atorvastatin side effects heart palpitations?When genetic tenofovir alafenamide be available in us?Mebendazole for kids price?Guselkumab patent expiration?
See the DrugPatentWatch profile for Dymista
Dymista received FDA approval in 2014. [1]
Patent information for Dymista can be found on DrugPatentWatch.com. [2]
Dymista is a nasal spray medication used to treat symptoms associated with allergic rhinitis. It is manufactured by Meda Pharmaceuticals. [1]
Dymista contains fluticasone propionate, a corticosteroid, and azelastine hydrochloride, an antihistamine. [1]
Clinical studies have shown that Dymista is effective in reducing nasal and ocular symptoms of allergic rhinitis. [1]
Other Questions About Dymista :